Anxiety Disorders
📧 Sign up to get email alerts when something new happens for Anxiety Disorders.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-02-09FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (First Nation Group, LLC)
FDA approved the original application for a generic doxepin hydrochloride product from First Nation Group, LLC, enabling its marketing in th…
-
FDA approval · 2022-02-02FDA Approved: CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approved the original application for CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE (ANDA 211925) from Micro Labs Limited.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants [Phase 1]
Phase 1 bioequivalence study of paroxetine and PAXIL under fasting conditions in healthy Mexican participants completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Impact of CBD-Rich Oil on Aversive Memory Reconsolidation [Phase 1, Phase 2]
A clinical trial investigating how CBD-rich oil affects aversive memory reconsolidation in anxiety and fear, across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Treatments for Anxiety: Meditation and Escitalopram [Phase 4]
Phase 4 trial update examining meditation and escitalopram for anxiety disorders, completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders [Phase 2]
Phase 2 trial update on LSD treatment for anxiety symptoms in somatic disease or psychiatric anxiety disorders has completed.
-
FDA approval · 2021-11-12FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Diazepam from Hikma Pharmaceuticals USA Inc. under an ANDA, reflecting a regulatory action on th…
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: Psychotherapy for Anxiety in Children With Autism Spectrum Disorder [NA]
A completed clinical trial evaluating psychotherapy for anxiety in children with autism spectrum disorders; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Acceptance and Commitment Therapy for Older Adults [NA]
A completed clinical trial evaluated Acceptance and Commitment Therapy for older adults addressing psychological distress, anxiety, and depr…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Evaluating Stress Response and Anxiety Score in Paediatric Patients [Phase 2]
Phase 2 pediatric trial evaluating stress response and anxiety score in children undergoing anesthesia has completed recruitment and results…
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness [Phase 2]
Phase 2 study of MDMA-assisted psychotherapy for anxiety associated with a life-threatening illness has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Stabilizing Behavioral Rhythms to Improve Mental Health [Phase 2]
Phase 2 clinical trial update on stabilizing behavioral rhythms to improve mental health outcomes.
-
FDA approval · 2021-06-23FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved Natco Pharma USA LLC's supplemental application for Diazepam (generic).
-
EMA withdrawal · 2021-06-22EMA Withdrawn: Nodetrip (previously Xeristar) (duloxetine) — Esteve Pharmaceuticals, S.A.
The EMA has withdrawn Nodetrip (duloxetine) from Esteve Pharmaceuticals, covering indications in anxiety disorders, major depressive disorde…
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 [Phase 1, Phase 2]
A Phase 1/Phase 2 trial investigating recovery of damaged cells to address post-COVID-19 sequelae and related conditions. Current status is …
-
FDA approval · 2021-05-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam filed by Hikma Pharmaceuticals USA Inc., marking regulatory clearance for an additi…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Stress & Anxiety Dampening Effects of a Probiotic Supplement Compared to Placebo in Healthy Subjects [NA]
A completed clinical trial evaluated whether a probiotic supplement reduces stress and anxiety compared with placebo in healthy adults, with…
-
FDA approval · 2021-02-16FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for hydroxyzine pamoate.
-
FDA approval · 2021-02-08FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved a supplemental application for Diazepam from Natco Pharma USA LLC (ANDA 211998). This action confirms the continued approval/av…
-
FDA approval · 2021-02-05FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for chlordiazepoxide hydrochloride from Epic Pharma LLC. The approval pertains to the generic produc…
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM INTENSOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Diazepam Intensol from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for diazepam from Hospira, Inc., under an ANDA, indicating regulatory approval of the requested chan…
-
FDA approval · 2021-02-05FDA Approved: OXAZEPAM — Supplemental Application (TruPharma, LLC)
FDA approved a supplemental application for Oxazepam from TruPharma, LLC.
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM — Supplemental Application (Meridian Medical Technologies LLC)
The FDA approved a supplemental application for Diazepam submitted by Meridian Medical Technologies LLC.
-
FDA approval · 2021-02-05FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for chlordiazep oxide hydrochloride from Epic Pharma, LLC.